New Research Covers Current Trends and Future Directions of the High Performing Pharmaceutical...

Thu Jul 10, 2008 12:48pm EDT
 
[-] Text [+]
New Research Covers Current Trends and Future Directions of the High
Performing Pharmaceutical District Sales Managers

CHAPEL HILL, N.C., July 10 /PRNewswire/ -- "The DMs will be the key to
evolving the future sales model," a sales leader said in Best Practices, LLC's
latest report. The research establishes that the District Sales Manager (DM)
is the cornerstone of pharmaceutical sales force effectiveness. Continued
field force success depends largely on the ability of companies to evolve
their DM positions to meet the needs of the complex,
fast-changing bio-pharma industry.
    Best Practices, LLC initiated this research to help executives who oversee
or train bio-pharmaceutical field sales staff to understand how industry
pressures are accelerating sales force evolution and impacting district
manager effectiveness. Executives can use the forward-looking benchmarks in
this report to plan and implement changes needed to help DMs sustain high
performance levels.
    Report excerpt, "The High Performing Pharmaceutical District Sales
Manager: Current Trends & Future Directions," is available at
http://www3.best-in-class.com/rr965.htm
    Sample key findings that emerged from this research are the following:
    -- The DM Role Is Expected to Become a More Strategic Position -- Time &
Resources Are Shifting from Tactical to Strategic Activities
    -- Regional Managers Are a Source of Untapped Productivity -- Regional
Managers Are the First Source of Change
    The cross-industry report covers 26 leading bio-pharma companies and
interviewed forty-six managers and executives. Participants included Amgen,
Eli Lilly, Roche, Sanofi-Aventis, Merck, Abbott and Wyeth.
    For more information, on Best Practices, LLC's research and services,
contact Cameron Tew, Manager of Research and Publishing at Best Practices, LLC
at (919) 767-9246 or ctew@best-in-class.com.
    ABOUT BEST PRACTICES, LLC
    Best Practices, LLC, conducts work based on the simple yet profound
principle that organizations can chart a course to superior economic
performance by studying the best business practices, operating tactics and
winning strategies of world-class companies. Best Practices, LLC has been a
leader in pharmaceutical research and consulting for nearly 15 years; our
clients include 43 out of the top 50 pharmaceutical companies.
SOURCE  Best Practices, LLC

Media: Kimberly Hardin, +1-919-767-9221, khardin@best-in-class.com

 

Featured Broker sponsored link

Editor's Choice

A selection of our best photos from the past 24 hours.  Slideshow 

Most Popular on Reuters

  • Articles
  • Video